The Prognostic Value Of Myc, Bcl2 And Bcl6 Translocations And Protein Expressions In Young Patients With High-Risk Diffuse Large B-Cell Lymphoma Treated With R-Choep

Background: In young patients with high-risk diffuse large B-cell lymphoma (DLBCL) treatment with R-CHOEP (R-CHOP + etoposide) has been associated with improved outcome. Whether established prognostic markers in R-CHOP treated patients are prognostic in R-CHOEP treated patients remain to be investigated. In addition predictive markers for response to R-CHOEP need to be investigated.